S Schryber
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Cancer Cells and Metastasis
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 5
- Neutropenia and Cancer Infections 3
-
- Acute Myeloid Leukemia Research 2
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Joseph P. Eder (9 shared papers)Karen H. Antman (7 shared papers)W. David Henner (5 shared papers)Lowell E. Schnipper (6 shared papers)W. P. Peters (3 shared papers)Anthony Elias (5 shared papers)Robert W. Finberg (3 shared papers)M. Tracie Shea (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Science (1 paper)JNCI Journal of the National Cancer Institute (1 paper)PubMed (3 papers)
- Partner nations
- United StatesGermany
In The Last Decade
S Schryber
10 papers receiving 433 citations
Peers
Comparison fields: 5 of 52
- Hematology 132
- Oncology 221
- Cancer Research 104
- Pathology and Forensic Medicine 76
- Neurology 43
Countries citing papers authored by S Schryber
This map shows the geographic impact of S Schryber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Schryber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Schryber more than expected).
Fields of papers citing papers by S Schryber
This network shows the impact of papers produced by S Schryber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Schryber. The network helps show where S Schryber may publish in the future.
Co-authors
The 25 scholars most cited alongside S Schryber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 107 | |
| 2 | 1986 | 102 | |
| 3 | 1990 | 68 | |
| 4 | 1988 | 43 | |
| 5 | 1991 | 40 | |
| 6 | High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience. | 1987 | 38 |
| 7 | High-dose thiotepa alone and in combination regimens with bone marrow support. | 1990 | 32 |
| 8 | 1989 | 16 | |
| 9 | Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy. | 1986 | 7 |
| 10 | 1991 | 3 |
About S Schryber
S Schryber is a scholar working on Oncology, Hematology, Molecular Biology, Pathology and Forensic Medicine and Neurology, having authored 10 papers that have together received 456 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Neutropenia and Cancer Infections (3 papers), Acute Myeloid Leukemia Research (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Neuroblastoma Research and Treatments (2 papers), Multiple and Secondary Primary Cancers (1 paper) and Chemotherapy-induced organ toxicity mitigation (1 paper). The work is most often cited by research in Hematology (132 citations), Oncology (221 citations), Cancer Research (104 citations), Pathology and Forensic Medicine (76 citations) and Neurology (43 citations). S Schryber has collaborated with scholars based in United States and Germany. Frequent co-authors include Joseph P. Eder, Karen H. Antman, W. David Henner, Lowell E. Schnipper, W. P. Peters, Anthony Elias, Robert W. Finberg, M. Tracie Shea, D. W. Wilmore and Beverly A. Teicher. Their work appears in journals such as Journal of Clinical Oncology, Clinical Science, JNCI Journal of the National Cancer Institute and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.